2.36
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché AYTU Giù?
Forum
Previsione
Frazionamento azionario
Aytu Biopharma Inc Borsa (AYTU) Ultime notizie
What earnings revisions data tells us about Aytu BioPharma Inc.2025 Key Highlights & Precise Buy Zone Tips - newser.com
Using data models to predict Aytu BioPharma Inc. stock movementMarket Weekly Review & Low Volatility Stock Suggestions - newser.com
Aytu BioPharma to Present at Upcoming October 2025 Conferences - ACCESS Newswire
How to use Fibonacci retracement on Aytu BioPharma Inc.Analyst Upgrade & Community Supported Trade Ideas - newser.com
Why institutional investors increase stakes in Aytu BioPharma Inc. (AY20) stockAnalyst Upgrade & Verified Swing Trading Watchlists - newser.com
How institutional ownership impacts Aytu BioPharma Inc. stockWeekly Trade Analysis & Reliable Volume Spike Trade Alerts - newser.com
Aytu BioPharma Inc AY20 Stock Analysis and ForecastMomentum Trading Signals & Free Double Digit Growth Tips - earlytimes.in
What analysts say about Aytu BioPharma Inc stockTake Profit Strategies & Fast Profit Trading Tips - earlytimes.in
Is Aytu BioPharma Inc. (AY20) stock attractive for growth fundsJuly 2025 Levels & Risk Adjusted Swing Trade Ideas - newser.com
Can Aytu BioPharma Inc. (AY20) stock withstand sector downturnsEarnings Growth Report & Entry Point Strategy Guides - newser.com
Aytu BioPharma Reports Fiscal 2025 Earnings and EXXUA Launch Plans - MSN
Will Rising Interest Rates Hurt Lupin Limited’s Profit MarginsMarket Correction Analysis & Set Up Real-Time Alerts – It’s Free - earlytimes.in
Aytu BioPharma Inc. stock momentum explainedJuly 2025 Snapshot & High Accuracy Trade Alerts - newser.com
Applying sector rotation models to Aytu BioPharma Inc.Market Performance Report & Technical Pattern Recognition Alerts - newser.com
Aytu outlines EXXUA launch targeting $22B MDD market while streamlining ADHD portfolio - MSN
Is It Time to Lock in Profits on Mefcom Capital Markets Limited StockValue Stock Picks & Minimal Investment Capital Gains - earlytimes.in
What drives Aytu BioPharma Inc AY20 stock priceInterest Rate Changes & Minimal Risk High Reward - earlytimes.in
Aytu BioPharma at Lytham Partners: Strategic Realignment and Growth By Investing.com - Investing.com Canada
Aytu BioPharma (NASDAQ:AYTU) Downgraded by Wall Street Zen to “Hold” - Defense World
Aytu BioPharma (NASDAQ:AYTU) Given New $12.50 Price Target at Ascendiant Capital Markets - Defense World
Ascendiant Capital Maintains Aytu BioPharma (AYTU) Buy Recommendation - Nasdaq
Maxim Group Maintains Aytu BioPharma (AYTU) Buy Recommendation - Nasdaq
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):